feature photo

Resources

Funding Acknowledgements and Disclaimer

Each publication, presentation, press release or other documents will include a statement acknowledging the IMPAACT Network and must include an acknowledgement of National Institutes of Health (NIH) award support for the work and list the applicable grant award numbers.

Press Releases: prior to issuing a press release, the NIAID Program Officer must be notified in advance to allow for NIH review and approval coordination.

Please note that several of the suggested acknowledgements below require referencing additional grant award numbers and/or contract numbers, contact co-authors to ensure all applicable grant awards and/or contract numbers are acknowledged.

The following guidance is summarized below; please refer to the IMPAACT Network Manual of Procedures, Section 19 for a full description of the Network’s publications policies and procedures:

  • The IMPAACT Network and the specific protocol number should be included in the title and body of the manuscript (e.g., IMPAACT XXXX).
  • Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH), all components of the National Institutes of Health (NIH), under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), and by NICHD contract number HHSN275201800001I. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
  • If the work represented by the manuscript was directly supported by other sponsors, they should be acknowledged accordingly and in keeping with the terms of any applicable CTAs, MOUs, or other collaboration and sponsor agreements. For example, if study products were supplied by the manufacturer free of charge for use in the study, this should be acknowledged. It is the responsibility of the writing team chair and protocol team chair to ensure appropriate acknowledgement of contributors, sponsors, and collaborators.

For studies originating under the HPTN (including, but not limited to HPTN 027, 035, 046, 057, 059), please use the following acknowledgment (note we recognize this may be combined with other funding sources): “This study was supported by the HIV Prevention Trials Network (HPTN) and was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1AI046749, with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health and Office of AIDS Research.”

 

 

 

 

 

 

 

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.